♫musicjinni

Vaccine rollout may limit upside for industrial stocks

video thumbnail
The industrial sector escaped much of the pain felt by services businesses last year, as consumers used their spare time and money to purchase manufactured goods. Mike Hanson of Fisher Investments explains why he thinks vaccine rollouts may limit the upside for the sector.

#News #SectorsUpClose #markets

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en

Vaccine rollout may limit upside for industrial stocks

Vaccines put industrial and technology stocks into focus

U.S. regulators investigate Trump social media deal

Biden hits Trump on jobs, alleged 'losers' remark

Healthcare sector set for a reboot as pandemic eases

Merck ends COVID vaccine program

Investors in South African equities should choose wisely

Why the U.S. healthcare sector may be a good ‘reopening play’

Dow drops over 500 points on Bullard comments

Pfizer raises COVID-19 vaccine sales forecast

Biotechnology sector rides wave of vaccine rollouts

Facebook to invest $1 billion in news industry

Moderna CEO defends $130 COVID vaccine price

U.S. jobs market gains momentum in February

Wall Street returns to record highs

Outlook for U.S. airlines less than certain even as shares surge

Pfizer's COVID's vaccine over '90% effective'

S&P, Nasdaq hit records on jobless claims drop – Business

U.S. stocks drop on worries over recovery, tax hikes

Valneva looks beyond Europe for vaccine partner

Tesla's Cybertruck on display in New York

Stocks end down as Russia-Ukraine tensions heat up

S&P 500 ends down after rallying to best November ever

Dow climbs as Walmart, Home Depot boost optimism

Pfizer raises vaccine sales forecast to $33.5 billion

Novartis profit tops expectations

Vaccine developers plan joint safety pledge according to reports

U.S. begins first shipments of COVID-19 vaccine

Wall Street dives as shutdown worries resurface

S&P 500 dips, as healthcare weighs; Dow ends higher

Disclaimer DMCA